BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 23982113)

  • 1. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.
    Cohen LS; Joffe H; Guthrie KA; Ensrud KE; Freeman M; Carpenter JS; Learman LA; Newton KM; Reed SD; Manson JE; Sternfeld B; Caan B; Freeman EW; LaCroix AZ; Tinker LF; Booth-Laforce C; Larson JC; Anderson GL
    Menopause; 2014 Apr; 21(4):347-54. PubMed ID: 23982113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of yoga for vasomotor symptoms: a randomized controlled trial.
    Newton KM; Reed SD; Guthrie KA; Sherman KJ; Booth-LaForce C; Caan B; Sternfeld B; Carpenter JS; Learman LA; Freeman EW; Cohen LS; Joffe H; Anderson GL; Larson JC; Hunt JR; Ensrud KE; LaCroix AZ
    Menopause; 2014 Apr; 21(4):339-46. PubMed ID: 24045673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of exercise for menopausal symptoms: a randomized controlled trial.
    Sternfeld B; Guthrie KA; Ensrud KE; LaCroix AZ; Larson JC; Dunn AL; Anderson GL; Seguin RA; Carpenter JS; Newton KM; Reed SD; Freeman EW; Cohen LS; Joffe H; Roberts M; Caan BJ
    Menopause; 2014 Apr; 21(4):330-8. PubMed ID: 23899828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials.
    Guthrie KA; Larson JC; Ensrud KE; Anderson GL; Carpenter JS; Freeman EW; Joffe H; LaCroix AZ; Manson JE; Morin CM; Newton KM; Otte J; Reed SD; McCurry SM
    Sleep; 2018 Jan; 41(1):. PubMed ID: 29165623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial.
    Ensrud KE; Joffe H; Guthrie KA; Larson JC; Reed SD; Newton KM; Sternfeld B; Lacroix AZ; Landis CA; Woods NF; Freeman EW
    Menopause; 2012 Aug; 19(8):848-55. PubMed ID: 22433978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.
    Guthrie KA; LaCroix AZ; Ensrud KE; Joffe H; Newton KM; Reed SD; Caan B; Carpenter JS; Cohen LS; Freeman EW; Larson JC; Manson JE; Rexrode K; Skaar TC; Sternfeld B; Anderson GL
    Obstet Gynecol; 2015 Aug; 126(2):413-422. PubMed ID: 26241433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.
    Reed SD; Guthrie KA; Newton KM; Anderson GL; Booth-LaForce C; Caan B; Carpenter JS; Cohen LS; Dunn AL; Ensrud KE; Freeman EW; Hunt JR; Joffe H; Larson JC; Learman LA; Rothenberg R; Seguin RA; Sherman KJ; Sternfeld BS; LaCroix AZ
    Am J Obstet Gynecol; 2014 Mar; 210(3):244.e1-11. PubMed ID: 24215858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.
    Joffe H; Guthrie KA; Larson J; Cohen LS; Carpenter JS; Lacroix AZ; Freeman EW
    Menopause; 2013 Mar; 20(3):261-8. PubMed ID: 23435022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L
    Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
    Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
    JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of perimenopausal transdermal estradiol on self-reported sleep, independent of its effect on vasomotor symptom bother and depressive symptoms.
    Geiger PJ; Eisenlohr-Moul T; Gordon JL; Rubinow DR; Girdler SS
    Menopause; 2019 Nov; 26(11):1318-1323. PubMed ID: 31688579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.
    Lucas M; Asselin G; Mérette C; Poulin MJ; Dodin S
    Menopause; 2009; 16(2):357-66. PubMed ID: 19034052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause.
    Painovich JM; Shufelt CL; Azziz R; Yang Y; Goodarzi MO; Braunstein GD; Karlan BY; Stewart PM; Merz CN
    Menopause; 2012 Jan; 19(1):54-61. PubMed ID: 21968279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of women's treatment preferences for vasomotor symptoms due to menopause.
    Shiozawa A; Thurston RC; Cook E; Yang H; King DD; Kristy RM; Mancuso S
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(10):1117-1128. PubMed ID: 37650213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.
    Hitchcock CL; Prior JC
    Menopause; 2012 Aug; 19(8):886-93. PubMed ID: 22453200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations among Core Outcomes in Menopause-recommended vasomotor symptom outcomes in MsFLASH trials.
    Carpenter JS; Larson JC; Hunter MS; Lensen S; Chen CX; Guthrie KA
    Menopause; 2024 Jan; 31(1):3-9. PubMed ID: 37963308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial.
    Freeman MP; Hibbeln JR; Silver M; Hirschberg AM; Wang B; Yule AM; Petrillo LF; Pascuillo E; Economou NI; Joffe H; Cohen LS
    Menopause; 2011 Mar; 18(3):279-84. PubMed ID: 21037490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Continuous Transdermal Nitroglycerin for Treating Hot Flashes by Inducing Nitrate Cross-tolerance in Perimenopausal and Postmenopausal Women: A Randomized Clinical Trial.
    Huang AJ; Cummings SR; Ganz P; Schembri M; Raghunathan H; Vittinghoff E; Gibson CJ; Grady D
    JAMA Intern Med; 2023 Aug; 183(8):776-783. PubMed ID: 37273224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.
    Caan B; LaCroix AZ; Joffe H; Guthrie KA; Larson JC; Carpenter JS; Cohen LS; Freeman EW; Manson JE; Newton K; Reed S; Rexrode K; Shifren J; Sternfeld B; Ensrud K
    Menopause; 2015 Jun; 22(6):607-15. PubMed ID: 25405571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.